LexaGene Holdings Inc.
LexaGene Holdings Inc. (LXXGF) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001450416 · LXXGF · OTC · as of Jun 10, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001450416 · Updated hourly · Not investment advice
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
LexaGene Holdings Inc. (OTC: LXXGF) has submitted 31 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in . As a Healthcare sector company with CIK 0001450416, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is LexaGene Holdings Inc.'s most comprehensive regulatory disclosure. The most recent LexaGene Holdings Inc. 10-K was filed on — for fiscal year ending —. Historical LXXGF 10-K annual reports are available from 2008 through —.
Investors researching LexaGene Holdings Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
LXXGF SEC Filings · 8 questionsLexaGene Holdings Inc. (LXXGF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 31 filings and access original documents at no cost. LexaGene Holdings Inc.'s CIK is 0001450416.